MedTrace Logo

The Effects of an Acute Bout of Exercise on Alcohol and Cocaine Craving - an fNIRS Study

NCT03502486 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-04-20

No results posted yet for this study

Summary

The study is a crossover randomised controlled trial. Alcohol or cocaine dependent participants will be recruited from inpatient and outpatient psychiatric treatment centres, on the approval of their treating physician. A healthy control group will be recruited using online advertising. All participants will undergo each of three conditions in a randomised order; 1) 20 minutes of cycle ergometry at 50-60% of maximum heart rate; 2) 20 minutes of exercise at 70-80% of maximum heart rate; 3) 20 minutes of quiet reading. Immediately before and after each condition, participants will be asked to complete a computerised Stroop test, watch a film containing substance-related images, and self-report craving levels. During the Stroop test and film viewing, participants' neural activity will be measured via functional near-infrared spectroscopy

Conditions

Interventions

OTHER

Moderate exercise

20 minutes of cycle ergometry at 50-60% of heart rate max

OTHER

Intense exercise

20 minutes of cycle ergometry at 70-80% of heart rate max

OTHER

Reading

20 minutes of seated reading

Sponsors & Collaborators

  • Psychiatric Hospital of the University of Basel

    collaborator OTHER

  • University of Basel

    lead OTHER

Principal Investigators

  • Flora Colledge, PhD · University of Basel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-05
Primary Completion
2019-08-31
Completion
2020-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03502486 on ClinicalTrials.gov